Review and validation of survival extrapolation in NICE appraisals of cancer immunotherapies

An article authored by Ash Bullement has been published in the Journal of Medical Economics on the topic of survival extrapolation for patients treated with cancer immunotherapies.

The article presents a review of extrapolation methods presented in company submissions to NICE, and assesses the accuracy of these extrapolations compared with later data.

You can read the article for free here